发明名称 INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R) PROTEIN SRM/MRM ASSAY
摘要 <p>The current disclosure provides for specific peptides from the Insulin-Like Growth Factor 1 Receptor (IGF-1R) protein and the derived ionization characteristics of those peptides that are advantageous for quantifying the IGF-1R directly in formalin fixed biological samples by the method of Selected Reaction Monitoring (SRM) mass spectrometry. Such fixed biological samples include: formalin-fixed tissue/cells, formalin-fixed/paraffin embedded (FFPE) tissue/cells, FFPE tissue blocks and cells from those blocks, and formalin fixed and paraffin embedded tissue culture cells. IGF-1R protein is quantitated in biological samples by the method of SRM/MRM mass spectrometry by quantitating one or more of the peptides described herein. The peptides can be quantitated if they reside in a modified or an unmodified form. Examples of potentially modified forms of an IGF-1R peptides include those bearing phosphorylation of a tyrosine, threonine, serine, and/or other amino acid residues within the peptide sequence.</p>
申请公布号 EP2517011(A1) 申请公布日期 2012.10.31
申请号 EP20100843597 申请日期 2010.12.22
申请人 EXPRESSION PATHOLOGY, INC. 发明人 KRIZMAN, DAVID, B.;HEMBROUGH, TODD;THYPARAMBIL, SHEENO
分类号 G01N33/50;G01N33/68;G01N33/74 主分类号 G01N33/50
代理机构 代理人
主权项
地址